This inventor holds 3 USPTO granted patents. Top assignee: Regent Court Technologies, LLC. Active years: 2002-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2005
Title: The Innovations of Robert J DeLorenzo
Introduction
Robert J DeLorenzo is a notable inventor based in Richmond, VA (US). He has made significant contributions to the field of pharmacology, particularly through his work on monoamine oxidase (MAO) inhibitors. With a total of 3 patents, his inventions have the potential to impact various therapeutic applications.
Latest Patents
One of DeLorenzo's latest patents focuses on monoamine oxidase (MAO) inhibitors and their uses. This invention provides a group of tobacco alkaloids, tobacco extract, Yerba maté extract, and extracts from chewing gum and lozenges that act as modulators of MAO activity. These compounds inhibit the MAO enzyme, preventing its biological activity. The MAO inhibitors developed by DeLorenzo can increase levels of norepinephrine, dopamine, and serotonin in the brain and other tissues. This increase can lead to a wide variety of pharmacological effects, making these inhibitors useful for treating conditions such as depression, attention disorders, mood disorders, Parkinson's disease, and smoking cessation.
Career Highlights
DeLorenzo is associated with Regent Court Technologies, LLC, where he continues to innovate in the field of pharmacology. His work has garnered attention for its potential to address significant health issues through novel therapeutic approaches.
Collaborations
Some of his notable coworkers include Jonnie R Williams and Harold R Burton, who have contributed to the collaborative efforts within the company.
Conclusion
Robert J DeLorenzo's work in developing MAO inhibitors showcases his commitment to advancing therapeutic solutions for various health challenges. His innovations hold promise for improving the quality of life for many individuals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile